Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4L8M

Human p38 MAP kinase in complex with a Dibenzoxepinone

4L8M の概要
エントリーDOI10.2210/pdb4l8m/pdb
関連するPDBエントリー3QUD 3QUE
分子名称Mitogen-activated protein kinase 14, octyl beta-D-glucopyranoside, N-[2-fluoro-5-({9-[2-(morpholin-4-yl)ethoxy]-11-oxo-6,11-dihydrodibenzo[b,e]oxepin-3-yl}amino)phenyl]benzamide, ... (4 entities in total)
機能のキーワードprotein kinase, selective p38 inhibitor, sar, dibenzoxepinone derivative, dibenzoxepinone, transferase-transferase inhibitor complex, transferase/transferase inhibitor
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計42421.40
構造登録者
Richters, A.,Mayer-Wrangowski, S.C.,Gruetter, C.,Rauh, D. (登録日: 2013-06-17, 公開日: 2013-10-30, 最終更新日: 2023-09-20)
主引用文献Baur, B.,Storch, K.,Martz, K.E.,Goettert, M.I.,Richters, A.,Rauh, D.,Laufer, S.A.
Metabolically Stable Dibenzo[b,e]oxepin-11(6H)-ones as Highly Selective p38 MAP Kinase Inhibitors: Optimizing Anti-Cytokine Activity in Human Whole Blood.
J.Med.Chem., 56:8561-8578, 2013
Cited by
PubMed Abstract: Five series of metabolically stable disubstituted dibenzo[b,e]oxepin-11(6H)-ones were synthesized and tested in a p38α enzyme assay for their inhibition of tumor necrosis factor-α (TNF-α) release in human whole blood. Compared to the monosubstituted dibenzo[b,e]oxepin-11(6H)-one derivatives, it has been shown that the additional introduction of hydrophilic residues at position 9 leads to a substantial improvement of the inhibitory potency and metabolic stability. Using protein X-ray crystallography, the binding mode of the disubstituted dibenzoxepinones and the induction of a glyince flip in the hinge region were confirmed. The most potent compound of this series, 32e, shows an outstanding biological activity on isolated p38α, with an IC50 value of 1.6 nM, extraordinary selectivity (by a factor >1000, Kinase WholePanelProfiler), and low ATP competitiveness. The ability to inhibit the release of TNF-α from human whole blood was optimized down to an IC50 value of 125 nM. With the promising dibenzoxepinone inhibitor 3i, a pharmacokinetic study in mice was conducted.
PubMed: 24131218
DOI: 10.1021/jm401276h
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.1 Å)
構造検証レポート
Validation report summary of 4l8m
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon